Krystyna Gołembiowska

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Major Depressive Disorder

Prefrontal Cortex

Top Venues

International journal of molecular sciences

Psychopharmacology

Neurotoxicity research

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Wojtas, Krystyna Gołembiowska
Molecular and Medical Aspects of Psychedelics. International journal of molecular sciences 25 (1) (2023)
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak-Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study. International journal of molecular sciences 25 (1) (2023)
Adam Wojtas, Krystyna Gołembiowska
Molecular and Medical Aspects of Psychedelics. International journal of molecular sciences 25 (1) (2023)
Adam Wojtas, Krystyna Gołembiowska
Molecular and Medical Aspects of Psychedelics. International journal of molecular sciences 25 (1) (2023)
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak-Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study. International journal of molecular sciences 25 (1) (2023)
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak-Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska
Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study. International journal of molecular sciences 25 (1) (2023)
Monika Herian, Mateusz Skawski, Adam Wojtas, Małgorzata K Sobocińska, Karolina Noworyta, Krystyna Gołembiowska
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe. Psychopharmacology 238 (8) (2021)
Monika Herian, Adam Wojtas, Małgorzata Katarzyna Sobocińska, Mateusz Skawski, Alejandro González-Marín, Krystyna Gołembiowska
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission. Pharmacological reports : PR 72 (6) (2020)
Adam Wojtas, Monika Herian, Mateusz Skawski, Małgorzata Sobocińska, Alejandro González-Marín, Karolina Noworyta-Sokołowska, Krystyna Gołembiowska
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats. Neurotoxicity research 39 (2) (2020)